Construction and Activity Evaluation of xCas9 and SpCas9-NG Nicking Mutants
ZHANG Ning1, QIN Huai-Yuan1, XIN Jing-Jing1, ZHAO Jin-Shan1, BAO Han-Xun2, LI He-Gang*
1 College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China; 2 Jiaozhou Bureau of Agriculture and Rural Areas, Qingdao 266300, China
Abstract The commonly used CRISPR/Cas9 system only recognizes targets with a NGG protospacer-adjacent motif (PAM) sequence, while the evolved xCas9 and SpCas9-NG systems can recognize targets with a NG PAM, which broadens the recognition range of CRISPR/Cas9. However, the off-target effects have always hindered the development and application of the CRISPR/Cas9 system. Previous studies showed that the double-nicking system could increase the specificity of DNA targeting. Four nicking mutants, named xCas9-D10A, SpCas9-NG-D10A, xCas9-H840A, and SpCas9-NG-H840A, and the corresponding single guide RNA (sgRNA) expression vectors were designed and constructed in this study to improve the specificity of gene editing of the CRISPR/Cas9 system. These vectors, with SSA-DKK1, SSA-DKK2 reporter plasmid, were co-transfected into sheep (Ovis aries) fibroblast cells through a specific plasmid combination, verifying cutting mutants activity with luciferase expression. The results showed that the SpCas9-NG-D10A and SpCas9-NG-H840A mutants had significantly greater reporter gene activity against most target vectors that recognize PAM as NG than the control group (P<0.05), and the xCas9-H840A variant had no activity at all.However, xCas9-D10A only showed cleavage activity in DKK1 gene. In contrast, the SpCas9-NG-D10A variant had stable activity and high efficiency in cutting DNA single strands, so this vector can be used for further research applications. The results of this study provides important reference data for the further research and application of NG PAM's Cas9 double-nicking system.
ZHANG Ning,QIN Huai-Yuan,XIN Jing-Jing, et al. Construction and Activity Evaluation of xCas9 and SpCas9-NG Nicking Mutants[J]. 农业生物技术学报, 2021, 29(6): 1206-1214.
[1] 艾元立, 陈康轩, 胡菲阳, 等. 2017. CRISPR/Cas9作用机制及研究进展[J].黑龙江畜牧兽医,(07): 74-77+83. (AI Y L, CHEN K X, HU F Y, et al.2017. Active mechanism and research progress of CRISPR/Cas9 system[J]. Heilongjiang Journal Animal Science and Veterinary Medicine.(07): 74-77, 83.) [2] 耿德玉, 原媛, 郭华荣. 2012. 双荧光素酶报告基因系统的应用研究进展[J]. 科技资讯, (021): 1-1. (GENG D Y, YUAN Y, GUO H R. 2012. Research progress of application of dual luciferase reporter gene system[J]. Science & Technology Information, (021): 1-1.) [3] 李江, 耿立召, 许建平. 2019. CRISPR/Cas9系统中引导RNA的研究进展[J]. 生物技术通报, 35(4): 108-115. ( LI J, GENG L Z, XU J P.2019. Research progress on guide RNA in CRISPR/Cas9 system[J]. Biotechnology Bulletin, 35(4): 108-115.) [4] 辛京京, 李和刚, 秦怀远, 等. 2020. CRISPR/AsCpf1双切刻系统构建初探[J]. 中国畜牧杂志, 56(12): 174-180. (XIN J J, LI H G, QIN H Y, et al.2020. Preliminary study on the construction of CRISPR/AsCpf1 double-nicking system[J]. Chinese Journal of Animal Science, 56(12): 174-180.) [5] Cho S W, Kim S, Kim Y, et al.2014. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases[J]. Genome Research, 24(1): 132-141. [6] Chiang T W, le Sage C, Larrieu D, et al.2016. CRISPR-Cas9(D10A) nickase-based genotypic and phenotypic screening to enhance genome editing[J]. Scientific reports, 6: 24356. [7] Fu Y, Foden J A, Khayter C, et al.2013. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells[J]. Nature Biotechnology, 31(9): 822-826. [8] Gopalappa R, Suresh B, Kim H H, et al.2018. Paired D10A Cas9 nickases are sometimes more efficient than individual nucleases for gene disruption[J]. Nucleic Acids Research, 46(12): e71. [9] Hu J H, Miller S M, Geurts M H, et al.2018. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity[J]. Nature, 556(7699): 57-63. [10] Hiroshi N, Xi S, Soh I, et al.2018. Engineered CRISPR-Cas9 nuclease with expanded targeting space[J]. Science, 361(6408): 1259-1262. [11] Liu C, Zhang L, Liu H, et al.2017. Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications[J]. Journal of Controlled Release, 266: 17-26. [12] Lim K R Q, Yoon C, Yokota T.2018. Applications of CRISPR/Cas9 for the treatment of duchenne muscular dystrophy[J]. Journal of Personalized Medicine, 8(4): 38. [13] Liu X, Wu S, Xu J,et al.2017. Application of CRISPR/Cas9 in plant biology[J]. Acta Pharmaceutica Sinica. B, 7(3): 292-302. [14] Liu L, Yin M, Wang M, et al.2019. Phage AcrIIA2 DNA mimicry: Structural basis of the CRISPR and anti-CRISPR arms race[J]. Molecular Cell, 73(3): 611-620. [15] Pattanayak V, Lin S, Guilinger J P, et al.2013. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity[J]. Nature Biotechnology, 31(9): 839-843. [16] Ran F A, Hsu P D, Wright J, et al.2013. Genome engineering using the CRISPR-Cas9 system[J]. Nature protocols, 8(11): 2281-2308. [17] Ran F, Hsu P, Lin C Y, et al.2013. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity[J]. Cell, 154(6): 1380-1389. [18] Walton R T, Christie K A, Whittaker M N, et al.2020. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants[J]. Science, 368(6488): 290-296. [19] Sternberg S H, Redding S, Jinek M, et al.2014. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9[J]. Nature, 507(7490): 62-67. [20] Trevino A E, Zhang F.2014. Genome editing using Cas9 nickases[J].Methods Enzymol, 546: 161-174.
